To report a rare case of papillary thyroid carcinoma (PTC) with delayed multiple metastases to the brain and lungs, highlighting the clinical significance of such occurrences.
Key Findings:
The patient developed brain and lung metastases six years after total thyroidectomy for PTC, underscoring the potential for late recurrence.
Anlotinib treatment resulted in partial remission of lung metastases, suggesting its viability as a treatment option in resistant cases.
Interpretation:
This case highlights the potential for delayed and uncommon distant metastases in PTC, emphasizing the need for ongoing surveillance and consideration of alternative treatments.
Limitations:
The case is a single report and may not represent broader trends in PTC metastasis, limiting its applicability.
Limited follow-up duration may not capture long-term outcomes, necessitating further studies.
Conclusion:
The findings suggest that PTC can lead to delayed metastases, and anlotinib may be a viable treatment option, reinforcing the importance of lifelong monitoring for patients.
